229 related articles for article (PubMed ID: 34704673)
1. Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa-induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia.
Cho DY; Zhang S; Skinner DF; Lim DJ; Banks C; Grayson JW; Tearney GJ; Rowe SM; Woodworth BA
Int Forum Allergy Rhinol; 2022 May; 12(5):690-698. PubMed ID: 34704673
[TBL] [Abstract][Full Text] [Related]
2. Assessment of acquired mucociliary clearance defects using micro-optical coherence tomography.
Tipirneni KE; Grayson JW; Zhang S; Cho DY; Skinner DF; Lim DJ; Mackey C; Tearney GJ; Rowe SM; Woodworth BA
Int Forum Allergy Rhinol; 2017 Sep; 7(9):920-925. PubMed ID: 28658531
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency.
Woodworth BA
Laryngoscope; 2015 Oct; 125 Suppl 7(0 7):S1-S13. PubMed ID: 25946147
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease.
Cho DY; Zhang S; Lazrak A; Grayson JW; Peña Garcia JA; Skinner DF; Lim DJ; Mackey C; Banks C; Matalon S; Woodworth BA
Int Forum Allergy Rhinol; 2019 Jan; 9(1):100-105. PubMed ID: 30152192
[TBL] [Abstract][Full Text] [Related]
5. The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.
Raju SV; Lin VY; Liu L; McNicholas CM; Karki S; Sloane PA; Tang L; Jackson PL; Wang W; Wilson L; Macon KJ; Mazur M; Kappes JC; DeLucas LJ; Barnes S; Kirk K; Tearney GJ; Rowe SM
Am J Respir Cell Mol Biol; 2017 Jan; 56(1):99-108. PubMed ID: 27585394
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cystic fibrosis transmembrane conductance regulator (CFTR) and ciliary beat frequency activation by the CFTR Modulators Genistein, VRT-532, and UCCF-152 in primary sinonasal epithelial cultures.
Conger BT; Zhang S; Skinner D; Hicks SB; Sorscher EJ; Rowe SM; Woodworth BA
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):822-7. PubMed ID: 23949358
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis transmembrane conductance regulator activation by the solvent ethanol: implications for topical drug delivery.
Cho DY; Skinner D; Zhang S; Fortenberry J; Sorscher EJ; Dean NR; Woodworth BA
Int Forum Allergy Rhinol; 2016 Feb; 6(2):178-84. PubMed ID: 26869199
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probability.
Zhang S; Blount AC; McNicholas CM; Skinner DF; Chestnut M; Kappes JC; Sorscher EJ; Woodworth BA
PLoS One; 2013; 8(11):e81589. PubMed ID: 24282612
[TBL] [Abstract][Full Text] [Related]
9. Effect of L-ascorbate on chloride transport in freshly excised sinonasal epithelia.
Cho DY; Hwang PH; Illek B
Am J Rhinol Allergy; 2009; 23(3):294-9. PubMed ID: 19490804
[TBL] [Abstract][Full Text] [Related]
10. Quercetin increases cystic fibrosis transmembrane conductance regulator-mediated chloride transport and ciliary beat frequency: therapeutic implications for chronic rhinosinusitis.
Zhang S; Smith N; Schuster D; Azbell C; Sorscher EJ; Rowe SM; Woodworth BA
Am J Rhinol Allergy; 2011; 25(5):307-12. PubMed ID: 22186243
[TBL] [Abstract][Full Text] [Related]
11. Medical reversal of chronic sinusitis in a cystic fibrosis patient with ivacaftor.
Chang EH; Tang XX; Shah VS; Launspach JL; Ernst SE; Hilkin B; Karp PH; Abou Alaiwa MH; Graham SM; Hornick DB; Welsh MJ; Stoltz DA; Zabner J
Int Forum Allergy Rhinol; 2015 Feb; 5(2):178-81. PubMed ID: 25363320
[TBL] [Abstract][Full Text] [Related]
12. A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease.
Sloane PA; Shastry S; Wilhelm A; Courville C; Tang LP; Backer K; Levin E; Raju SV; Li Y; Mazur M; Byan-Parker S; Grizzle W; Sorscher EJ; Dransfield MT; Rowe SM
PLoS One; 2012; 7(6):e39809. PubMed ID: 22768130
[TBL] [Abstract][Full Text] [Related]
13. Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis.
Cho DY; Skinner D; Mackey C; Lampkin HB; Elder JB; Lim DJ; Zhang S; McCormick J; Tearney GJ; Rowe SM; Woodworth BA
Int Forum Allergy Rhinol; 2019 Jun; 9(6):629-637. PubMed ID: 30657641
[TBL] [Abstract][Full Text] [Related]
14. Hesperidin stimulates cystic fibrosis transmembrane conductance regulator-mediated chloride secretion and ciliary beat frequency in sinonasal epithelium.
Azbell C; Zhang S; Skinner D; Fortenberry J; Sorscher EJ; Woodworth BA
Otolaryngol Head Neck Surg; 2010 Sep; 143(3):397-404. PubMed ID: 20723778
[TBL] [Abstract][Full Text] [Related]
15. Controlled delivery of ciprofloxacin and ivacaftor via sinus stent in a preclinical model of Pseudomonas sinusitis.
Lim DJ; McCormick J; Skinner D; Zhang S; Elder JB; McLemore JG; Allen M; West JM; Grayson JW; Rowe SM; Woodworth BA; Cho DY
Int Forum Allergy Rhinol; 2020 Apr; 10(4):481-488. PubMed ID: 31872532
[TBL] [Abstract][Full Text] [Related]
16. Porcine nasal epithelial cultures for studies of cystic fibrosis sinusitis.
Dean N; Ranganath NK; Jones B; Zhang S; Skinner D; Rowe SM; Sorscher EJ; Woodworth BA
Int Forum Allergy Rhinol; 2014 Jul; 4(7):565-70. PubMed ID: 24733748
[TBL] [Abstract][Full Text] [Related]
17. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
18. Chlorogenic Acid Activates CFTR-Mediated Cl- Secretion in Mice and Humans: Therapeutic Implications for Chronic Rhinosinusitis.
Illing EA; Cho DY; Zhang S; Skinner DF; Dunlap QA; Sorscher EJ; Woodworth BA
Otolaryngol Head Neck Surg; 2015 Aug; 153(2):291-7. PubMed ID: 26019132
[TBL] [Abstract][Full Text] [Related]
19. Red ginseng aqueous extract improves mucociliary transport dysfunction and histopathology in CF rat airways.
Cho DY; Zhang S; Skinner D; Koch CG; Smith MJ; Lim DJ; Grayson JW; Tearney GJ; Rowe SM; Woodworth BA
J Cyst Fibros; 2023 Nov; 22(6):1113-1119. PubMed ID: 37704464
[TBL] [Abstract][Full Text] [Related]
20. Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.
Rowe SM; Heltshe SL; Gonska T; Donaldson SH; Borowitz D; Gelfond D; Sagel SD; Khan U; Mayer-Hamblett N; Van Dalfsen JM; Joseloff E; Ramsey BW;
Am J Respir Crit Care Med; 2014 Jul; 190(2):175-84. PubMed ID: 24927234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
